For more than 15 years, much of the Alzheimer’s Disease establishment has focused its attention—and millions of research dollars—on the theory that the disease primarily is caused by the build-up of plaque, called amyloid beta, in the brain. But what if that theory is based on flawed data?
Subscribe to:
Post Comments (Atom)
< + > Connecticut’s Life Sciences Industry with BioCT – Life Sciences Today Podcast Episode 17
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Jodie Gillon, CEO...

-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
The following is a guest article by Ladd Wiley, Senior Vice President for Global Corporate Affairs, Public Policy, and Advocacy at Epic , ...
-
Robert Connely of Pega says patching legacy systems will give way to true health IT modernization, a security breakthrough will lead artific...
No comments:
Post a Comment